Suppr超能文献

高剂量口服激肽释放酶治疗特发性男性不育症的效果:通过无透明带仓鼠卵体外穿透试验进行评估。

Effect of high dose oral Kallikrein treatment in men with idiopathic subfertility: evaluation by means of in vitro penetration test of zona free hamster ova.

作者信息

Comhaire F, Vermeulen L

出版信息

Int J Androl. 1983 Apr;6(2):168-72. doi: 10.1111/j.1365-2605.1983.tb00335.x.

Abstract

High dose oral Kallikrein treatment (600 U Padutine per day) was given to 10 infertile men with poor semen quality. After 3 months of this treatment no pregnancies occurred, and no significant changes in routine semen characteristics were observed. Moreover, the capacity of the spermatozoa to migrate in vitro and to penetrate zona free hamster ova remained unchanged after Kallikrein ingestion. It is concluded that Kallikrein treatment was ineffective in these men.

摘要

对10名精液质量差的不育男性给予大剂量口服激肽释放酶治疗(每天600单位Padutine)。经过3个月的这种治疗,没有发生妊娠,并且未观察到常规精液特征有显著变化。此外,摄入激肽释放酶后,精子在体外迁移和穿透去透明带仓鼠卵的能力保持不变。得出的结论是,激肽释放酶治疗对这些男性无效。

相似文献

7
Inability of round acrosomeless human spermatozoa to penetrate zona-free hamster ova.
Arch Androl. 1983 Oct;11(2):167-9. doi: 10.3109/01485018308987477.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验